Price Action to Note: Is Buying Universal American Corporation Here a Winning Strategy?

Price Action to Note: Is Buying Universal American Corporation Here a Winning Strategy?

The stock of Universal American Corporation (NYSE:UAM) hit a new 52-week high and has $15.42 target or 55.00% above today’s $9.95 share price. The 8 months bullish chart indicates low risk for the $619.13M company. The 1-year high was reported on Nov, 21 by Barchart.com. If the $15.42 price target is reached, the company will be worth $340.52 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 378,356 shares traded hands. Universal American Corporation (NYSE:UAM) has risen 28.13% since April 19, 2016 and is uptrending. It has outperformed by 24.27% the S&P500.

Universal American Corporation (NYSE:UAM) Ratings Coverage

Out of 2 analysts covering Universal American Corporation (NYSE:UAM), 0 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 0 are positive. Universal American Corporation has been the topic of 2 analyst reports since August 21, 2015 according to StockzIntelligence Inc. As per Thursday, November 17, the company rating was upgraded by Raymond James.

According to Zacks Investment Research, “Universal American Corp. offers a range of health insurance and managed care products and services, and is dedicated to working collaboratively with doctors, pharmacists and other caring professionals to improve the health and well-being of its members. It offers these services primarily to the senior population. The Company’s principal health insurance products for the senior market are Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. Universal American also provides administrative services for senior market insurance and non-insurance programs to both affiliated and unaffiliated insurance companies and prescription benefit management services to state pharmacy assistance programs through a number of group contracts. Formerly known as Universal American Financial Corp., the company is headquartered in Rye Brook, New York.”

More notable recent Universal American Corporation (NYSE:UAM) news were published by: Foxbusiness.com which released: “Why Universal American Corporation Shares Are Up 10.7% Today” on November 17, 2016, also Prnewswire.com with their article: “SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of …” published on November 18, 2016, Businesswire.com published: “Universal American Corp. Reports 2016 Third Quarter Results” on November 08, 2016. More interesting news about Universal American Corporation (NYSE:UAM) were released by: Businesswire.com and their article: “Universal American Corp. Announces Pricing of $100 Million Private Offering of …” published on June 22, 2016 as well as Businesswire.com‘s news article titled: “Universal American Corp. Announces Closing of $115 Million Private Offering of …” with publication date: June 27, 2016.

UAM Company Profile

Universal American Corp., incorporated on December 22, 2010, provides an array of health insurance and managed care services and products to people covered by Medicare and Medicaid. The Company’s divisions include Medicare Advantage, Management Services Organization (MSO) and Medicaid. The Firm also operates in Corporate & Other segment, which reflects the activities of its holding firm and other ancillary operations. It has developed a primary care physician alignment strategy, which is branded as The Healthy Collaboration. It operates approximately 20 Medicare Shared Saving Program Accountable Care Organizations (MSSP ACOs) and a Next Generation ACO, including approximately 3,200 participating providers with over 236,000 assigned Medicare fee-for-service beneficiaries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment